How we supported a CNS mid-size pharma to better understand a new competitor and safeguard its position in the EU
The challenge: Understanding the impact of a new entrant on existing business A…
How we ensured a Top-20 Pharma never missed the latest clinical / R&D and market-related updates in the Multiple Sclerosis space.
The Challenge: Staying updated with the latest advancements in the Multiple…
How we helped a CNS mid-size pharma understand a new competitor in the EU after researching its sales force.
The Challenge: Assessing the impact of a new competitive entry in the CNS space…
Are AAVs really under threat?
Gene therapies can be the answer to treating, preventing, or curing various…
Taking a view at the current multiple sclerosis landscape: hype, promises and successes...
The multiple sclerosis (MS) landscape includes several assets promising a…
Migraine treatments and what the future holds
Migraine remains a condition with no cure and without a fully understood…